SCHEMBL2942797

SCHEMBL2942797

O=C(Nc1ccc(Cl)cc1)c1oc2cccnc2c1NC(=O)C1CCC(N2CCCC2)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 5/20 0.48
▸ KMT2A Q03164 5/20 0.48
▸ POLB P06746 2/20 0.48
▸ MAPT P10636 7/20 0.46
▸ HSD17B10 Q99714 4/20 0.46
▸ KDM4E B2RXH2 4/20 0.46
▸ TSHR P16473 3/20 0.46
▸ TP53 P04637 4/20 0.46
▸ ALDH1A1 P00352 3/20 0.46
▸ HPGD P15428 2/20 0.46
▸ HTT P42858 2/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ LMNA P02545 1/20 0.40
▸ DHODH Q02127 1/20 0.40
▸ NPSR1 Q6W5P4 1/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2942795 1.00 MEN1 (0.48) MEN1KMT2APOLBMAPTHSD17B10
SCHEMBL2949880 0.93 MEN1 (0.47) MEN1KMT2APOLBMAPTHSD17B10
SCHEMBL2949882 0.93 MEN1 (0.47) MEN1KMT2APOLBMAPTHSD17B10
SCHEMBL13290919 0.91 MAPT (0.57) MEN1KMT2APOLBMAPTHSD17B10
SCHEMBL2944866 0.91 SMN1; SMN2 (0.45) MEN1KMT2AKDM4ETSHRTP53
SCHEMBL2944863 0.91 SMN1; SMN2 (0.45) MEN1KMT2AKDM4ETSHRTP53
SCHEMBL2944781 0.87 MEN1 (0.45) MEN1KMT2APOLBMAPTHSD17B10
SCHEMBL2944778 0.87 MEN1 (0.45) MEN1KMT2APOLBMAPTHSD17B10
SCHEMBL13744994 0.86 MEN1 (0.67) MEN1KMT2APOLBMAPTHSD17B10
SCHEMBL2949749 0.84 MEN1 (0.44) MEN1KMT2APOLBMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7737161-B2 Condensed furan compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-06-15 — — US claimed
US-20090156803-A1 Condensed furan compounds KAWAGUCHI TAKAYUKI 2009-06-18 — — US claimed
US-20060094724-A1 Fused furan compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2006-05-04 — — US claimed
EP-1582521-A1 FUSED FURAN COMPOUND TANABE SEIYAKU CO., LTD. (JP) 2005-10-05 — — EP claimed
US-7737161-B2 Condensed furan compounds MITSUBISHI TANABE PHARMA CORPORATION (JP) 2010-06-15 — — US disclosed
US-20090156803-A1 Condensed furan compounds KAWAGUCHI TAKAYUKI 2009-06-18 — — US disclosed
US-7514449-B2 Fused furan compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-04-07 — — US disclosed
US-20060094724-A1 Fused furan compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2006-05-04 — — US disclosed
EP-1582521-A1 FUSED FURAN COMPOUND TANABE SEIYAKU CO., LTD. (JP) 2005-10-05 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156803-A1 Condensed furan compounds F2, F12, F11 MEN1 1453/4885KMT2A 2033/4885POLB 2463/4885
US-20060094724-A1 Fused furan compound F2, F12, F11 MEN1 1870/4885KMT2A 1957/4885POLB 3282/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback